NCT05190952
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Ain Shams university hospitals Cairo, Al Abbassia, Egypt
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,095 public trials
2,042 recruiting studies
Lymphoproliferative Disorders trial results
NCT00924326
- Conditions
- Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma, +21 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
- Locations
-
- Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
- Providence Cancer Center Anchorage, Alaska, United States
- Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
- Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise, Idaho, United States
NCT04172467
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
- Locations
-
- Privatärztliche Praxis; Innere Medizin, Hämatologie, Internistische Onkologie Kaiserslautern, Germany
NCT01712789
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Medical University of Graz Graz, Austria
- Medizinische Universitat Innsbruck Innsbruck, Austria
- Wilhelminenspital Vienna Vienna, Austria
- Medical University of Vienna Vienna, Austria
NCT02083250
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, +19 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT01186640
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- University Hospital Cologne Cologne, Germany
Completed
Obinutuzumab in Combination With Ibrutinib in Treating Patients With Relapsed Mantle Cell Lymphoma
NCT02736617
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
Completed
A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line Therapy
NCT01556776
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University Hospital Cologne Cologne, Germany
- German CLL Study Group Cologne, Germany
Completed
TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma
NCT02652468
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States